Your browser doesn't support javascript.
loading
Optimizing IFN Alpha Therapy against Myeloproliferative Neoplasms.
Hermange, Gurvan; Cournède, Paul-Henry; Plo, Isabelle.
Afiliação
  • Hermange G; Université Paris-Saclay, CentraleSupélec, Laboratory of Mathematics and Informatics (MICS), Gif-sur-Yvette, France (G.H., P.-H.C.); INSERM U1287, Villejuif, France (I.P.); Gustave Roussy, Villejuif, France (I.P.); and Université Paris-Saclay, Villejuif, France (I.P.).
  • Cournède PH; Université Paris-Saclay, CentraleSupélec, Laboratory of Mathematics and Informatics (MICS), Gif-sur-Yvette, France (G.H., P.-H.C.); INSERM U1287, Villejuif, France (I.P.); Gustave Roussy, Villejuif, France (I.P.); and Université Paris-Saclay, Villejuif, France (I.P.) henry.cournede@centralesupelec.fr isabelle.plo@gustaveroussy.fr.
  • Plo I; Université Paris-Saclay, CentraleSupélec, Laboratory of Mathematics and Informatics (MICS), Gif-sur-Yvette, France (G.H., P.-H.C.); INSERM U1287, Villejuif, France (I.P.); Gustave Roussy, Villejuif, France (I.P.); and Université Paris-Saclay, Villejuif, France (I.P.) henry.cournede@centralesupelec.fr isabelle.plo@gustaveroussy.fr.
J Pharmacol Exp Ther ; 387(1): 31-43, 2023 10.
Article em En | MEDLINE | ID: mdl-37391225
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Mieloproliferativos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Pharmacol Exp Ther Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Mieloproliferativos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Pharmacol Exp Ther Ano de publicação: 2023 Tipo de documento: Article